Details for New Drug Application (NDA): 017042
✉ Email this page to a colleague
NDA 017042 describes FLUORINE F-18, which is a drug marketed by Ge Healthcare and is included in one NDA. Additional details are available on the FLUORINE F-18 profile page.
The generic ingredient in FLUORINE F-18 is sodium fluoride f-18. There are one thousand four hundred and seventy-two drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the sodium fluoride f-18 profile page.
The generic ingredient in FLUORINE F-18 is sodium fluoride f-18. There are one thousand four hundred and seventy-two drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the sodium fluoride f-18 profile page.
Summary for 017042
| Tradename: | FLUORINE F-18 |
| Applicant: | Ge Healthcare |
| Ingredient: | sodium fluoride f-18 |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 017042
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 2mCi/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
